CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income	$ 19,111	$ 23,427
Adjustments to reconcile net income to net cash from operating activities:
Provision for loan losses	1,903	5,733
Depreciation and amortization	3,733	3,909
Accretion and amortization	(97)	1,507
Other gains, net	(122)	(148)
Net gain on sales of loans	(17,521)	(15,382)
Proceeds from sales of loans held for sale	460,268	431,676
Loans originated for sale	(454,501)	(404,525)
Earnings on bank-owned life insurance	(937)	(999)
Stock based compensation	407	0
Net change in:
Accrued interest receivable and other assets	(3,390)	(9,617)
Accrued expenses and other liabilities	13,616	9,619
Net cash from operating activities	22,470	45,200
Activity in securities available for sale:
Purchases	(165,023)	(464,966)
Sales	0	101,711
Maturities, prepayments, and calls	109,414	226,684
Activity in securities held to maturity:
Maturities, prepayments, and calls	0	14,675
Loan originations and principal collections, net	(7,786)	(142,203)
Cash paid for acquisition	(2,800)	0
Purchases of premises and equipment, net	(3,267)	(2,615)
Proceeds from sales of premises and equipment	208	74
Proceeds from sales of foreclosed assets	1,608	6,388
Net cash from investing activities	(67,646)	(260,252)
Cash flows from financing activities:
Net change in deposits	8,520	107,273
Net change in short-term borrowings	(7,850)	(3,500)
Proceeds from common stock issuance, net	51,392	0
Payments to tax authorities for stock-based compensation	(161)	0
Payments made on notes payable and other borrowings	(7,530)	0
Cash dividends on common stock	(539)	(17,544)
Net cash from financing activities	43,832	86,229
Net change in cash and cash equivalents	(1,344)	(128,823)
Beginning cash and cash equivalents	245,989	294,563
Ending cash and cash equivalents	244,645	165,740
Supplemental disclosures of cash flow information:
Interest paid on deposits and borrowed funds	21,882	11,774
Income taxes paid	4,364	0
Supplemental schedule of noncash investing and financing activities:
Loans transferred to foreclosed assets	1,521	6,151
Share-based liability awards modified to equity awards	$ 11,450	$ 0